Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Biotinidase deficiency has various symptoms and can be treated with biotin supplements.

The document's conclusion cannot be provided because the content is not available to parse.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

A new pain-measuring system using sensors and AI can effectively detect pain in mice, which may help assess pain in humans and develop treatments.

PBM helps improve cell survival in 3D tissue engineering.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

The journal Anais Brasileiros de Dermatologia has grown significantly in influence and visibility over the past decade.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

The grand round helps improve diagnoses and suggests new treatments for hair disorders.

Two genetic disorders affect biotin metabolism, causing severe skin, hair, and metabolic issues.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Normal BMI is linked to higher rates of androgenetic alopecia.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

The most common skin condition at the Baqai Institute in Karachi was scabies, and eczema was the most prevalent group of diseases.

The review helps improve diagnosis and treatment of challenging hair disorders.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

BDNF, TSH, fT4, anti-TPO, and 25-OH Vitamin D levels predict depression risk in patients with autoimmune thyroiditis and hypothyroidism.

Psoriasis patients are more likely to experience maladaptive daydreaming.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

Biotin supplements restored hair and resolved symptoms in a woman with biotin deficiency.